+
Uravi T & Wedge Reports Rs 445 Million FY25 Revenue
ECONOMY & POLICY

Uravi T & Wedge Reports Rs 445 Million FY25 Revenue

Uravi T & Wedge Lamps Limited (NSE: URAVI, BSE: 543930), a prominent manufacturer of incandescent and wedge-based automotive lamps, has announced its audited financial results for the fourth quarter and full financial year ending March 2025.
For FY25, the company reported consolidated total income of Rs 446 million, with earnings before interest, tax, depreciation, and amortisation (EBITDA) of Rs 67.5 million, reflecting an EBITDA margin of 15.13 per cent. The consolidated profit after tax (PAT) stood at Rs 19.5 million, with a PAT margin of 4.37 per cent and a basic earnings per share (EPS) of Rs 2.31.
In Q4 FY25 alone, Uravi recorded consolidated income of Rs 117.3 million and an EBITDA of Rs 20.8 million, yielding a margin of 17.73 per cent. PAT for the quarter reached Rs 8.1 million with an EPS of Rs 0.84.
On a standalone basis, Uravi reported an annual income of Rs 422.3 million and a PAT of Rs 17.9 million, with a 15.37 per cent EBITDA margin. Q4 standalone income totalled Rs 93.6 million, with a PAT of Rs 6.4 million and a margin of 6.84 per cent.
The results underscore the company’s stable financial performance and continued presence in the niche automotive lighting sector.

Uravi T & Wedge Lamps Limited (NSE: URAVI, BSE: 543930), a prominent manufacturer of incandescent and wedge-based automotive lamps, has announced its audited financial results for the fourth quarter and full financial year ending March 2025.For FY25, the company reported consolidated total income of Rs 446 million, with earnings before interest, tax, depreciation, and amortisation (EBITDA) of Rs 67.5 million, reflecting an EBITDA margin of 15.13 per cent. The consolidated profit after tax (PAT) stood at Rs 19.5 million, with a PAT margin of 4.37 per cent and a basic earnings per share (EPS) of Rs 2.31.In Q4 FY25 alone, Uravi recorded consolidated income of Rs 117.3 million and an EBITDA of Rs 20.8 million, yielding a margin of 17.73 per cent. PAT for the quarter reached Rs 8.1 million with an EPS of Rs 0.84.On a standalone basis, Uravi reported an annual income of Rs 422.3 million and a PAT of Rs 17.9 million, with a 15.37 per cent EBITDA margin. Q4 standalone income totalled Rs 93.6 million, with a PAT of Rs 6.4 million and a margin of 6.84 per cent.The results underscore the company’s stable financial performance and continued presence in the niche automotive lighting sector.

Next Story
Infrastructure Transport

Syama Prasad Mookerjee Port Partners to Redevelop Nimtala Ghat

Kolkata: Syama Prasad Mookerjee Port, Kolkata (SMPK), signed a Memorandum of Understanding (MoU) on Tuesday with PS Group Realty Private Limited to redevelop and beautify Nimtala Ghat as part of PS Group’s Corporate Social Responsibility (CSR) initiative.The agreement was formalised at SMPK’s Head Office at 15, Strand Road, in the presence of SMPK chairman Rathendra Raman, deputy chairman Samrat Rahi, PS Group directors Saurav Dugar, Gaurav Dugar, Arun Sancheti, and senior SMPK officials.Under the MoU, PS Group will undertake the full redevelopment and permitted construction of Nimtala Imm..

Next Story
Infrastructure Urban

CSIR-NCL and Covestro Collaborate to Upcycle Polyurethane Waste

In a move towards sustainable plastic waste management, Pune-based CSIR-National Chemical Laboratory (CSIR-NCL) signed a Memorandum of Understanding (MoU) with Covestro (India) Private Limited on Wednesday to develop innovative upcycling technologies for polyurethane waste.Polyurethane is notoriously difficult to recycle, with current methods often proving inefficient, costly, and environmentally harmful. This collaboration aims to address existing challenges, including high energy usage and deterioration of material quality during recycling.Ashish Lele, director of CSIR-NCL, stated, “This p..

Next Story
Infrastructure Urban

Torrent Pharma Seeks CCI Approval for Rs 195 Billion JB Chemicals Deal

Ahmedabad-based Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 195 billion deal.Upon completion, Torrent Pharmaceuticals will become India’s second most valuable pharmaceutical company.The move follows Torrent’s June announcement to acquire a majority stake in J B Chemicals for Rs 195 billion.“The proposed combination pertains to the acquisition of shareholding by Torrent Pharmaceuticals Ltd in J B Chemicals & Pharmaceuticals Ltd, followed by the merger of the target ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?